Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Airoldi

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
Cell|September 12, 2015
Reversible, Specific, Active Aggregates of Endogenous Proteins Assemble upon Heat StressEdward W J Wallace, Jamie L Kear-Scott, Evgeny V Pilipenko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckP Bossi, R Miceli, L D Locati, et al.
ESMO Open|April 11, 2022
Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude studyG Procopio, V E Chiuri, M Giordano, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2025
A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: Results in the pre-immunotherapy eraA Alberti, C Gurizzan, C Resteghini, et al.
ESMO Open|March 4, 2026
Prognostic impact of pathological complete response and response-adapted outcomes in patients with gastroesophageal adenocarcinoma treated with neoadjuvant or perioperative treatments: a multicentric cohort studyM Airoldi, A Cammarota, J A Carbonell-Asins, et al.
Breast (Edinburgh, Scotland)|July 17, 2017
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: New insights beyond clinical trials. The EVA studyM E Cazzaniga, M Airoldi, V Arcangeli, et al.
Autophagy|January 23, 2016
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Daniel J Klionsky, Kotb Abdelmohsen, Akihisa Abe, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
Cell|September 12, 2015
Reversible, Specific, Active Aggregates of Endogenous Proteins Assemble upon Heat StressEdward W J Wallace, Jamie L Kear-Scott, Evgeny V Pilipenko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckP Bossi, R Miceli, L D Locati, et al.
ESMO Open|April 11, 2022
Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude studyG Procopio, V E Chiuri, M Giordano, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2025
A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: Results in the pre-immunotherapy eraA Alberti, C Gurizzan, C Resteghini, et al.
ESMO Open|March 4, 2026
Prognostic impact of pathological complete response and response-adapted outcomes in patients with gastroesophageal adenocarcinoma treated with neoadjuvant or perioperative treatments: a multicentric cohort studyM Airoldi, A Cammarota, J A Carbonell-Asins, et al.
Breast (Edinburgh, Scotland)|July 17, 2017
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: New insights beyond clinical trials. The EVA studyM E Cazzaniga, M Airoldi, V Arcangeli, et al.
Autophagy|January 23, 2016
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Daniel J Klionsky, Kotb Abdelmohsen, Akihisa Abe, et al.
Pageof 14